MXPA02011553A - N-hidroxiformamidas sustituidas por biciclico heterobiciclilmetansulfonilamino. - Google Patents

N-hidroxiformamidas sustituidas por biciclico heterobiciclilmetansulfonilamino.

Info

Publication number
MXPA02011553A
MXPA02011553A MXPA02011553A MXPA02011553A MXPA02011553A MX PA02011553 A MXPA02011553 A MX PA02011553A MX PA02011553 A MXPA02011553 A MX PA02011553A MX PA02011553 A MXPA02011553 A MX PA02011553A MX PA02011553 A MXPA02011553 A MX PA02011553A
Authority
MX
Mexico
Prior art keywords
bicyclyl
hydroxyformamides
heterobicyclylmethanesulfonylamino
substituted
heterobicyclyl
Prior art date
Application number
MXPA02011553A
Other languages
English (en)
Inventor
Desmond John Best
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0012809A external-priority patent/GB0012809D0/en
Priority claimed from GB0104970A external-priority patent/GB0104970D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MXPA02011553A publication Critical patent/MXPA02011553A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Abstract

Los compuestos de la formula (I) donde R es hidrogeno, alquilo, alquenilo, alquinilo, arilo, hetemarilo o heterociclilo; y R1 es biciclilo o hetembiciclilo, son utiles para el tratamiento o profilaxis de condiciones mediadas por el s-CD23. (ver formula I).
MXPA02011553A 2000-05-25 2001-05-21 N-hidroxiformamidas sustituidas por biciclico heterobiciclilmetansulfonilamino. MXPA02011553A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0012809A GB0012809D0 (en) 2000-05-25 2000-05-25 Novel compounds
GB0104970A GB0104970D0 (en) 2001-02-28 2001-02-28 Novel compounds
PCT/EP2001/005798 WO2001090100A1 (en) 2000-05-25 2001-05-21 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides

Publications (1)

Publication Number Publication Date
MXPA02011553A true MXPA02011553A (es) 2003-04-25

Family

ID=26244357

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011553A MXPA02011553A (es) 2000-05-25 2001-05-21 N-hidroxiformamidas sustituidas por biciclico heterobiciclilmetansulfonilamino.

Country Status (20)

Country Link
US (2) US20040024066A1 (es)
EP (1) EP1289980B1 (es)
JP (1) JP2004501108A (es)
KR (1) KR20030005392A (es)
CN (1) CN1440400A (es)
AR (1) AR032341A1 (es)
AT (1) ATE282603T1 (es)
AU (1) AU2001267468A1 (es)
BR (1) BR0111074A (es)
CA (1) CA2410294A1 (es)
CZ (1) CZ20023853A3 (es)
DE (1) DE60107240T2 (es)
ES (1) ES2231513T3 (es)
HU (1) HUP0302121A2 (es)
IL (1) IL152990A0 (es)
MX (1) MXPA02011553A (es)
NO (1) NO20025549L (es)
NZ (1) NZ522594A (es)
PL (1) PL360116A1 (es)
WO (1) WO2001090100A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128376D0 (en) * 2001-11-27 2002-01-16 Smithkline Beecham Plc Novel compounds
GB0302431D0 (en) * 2003-01-30 2003-03-05 Glaxo Group Ltd Novel compounds
US7271195B2 (en) 2003-06-10 2007-09-18 Kalypsys, Inc. Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
CN1798733A (zh) * 2003-06-10 2006-07-05 凯利普西斯公司 作为组蛋白脱乙酰基酶抑制剂的疾病治疗用羰基化合物
KR100640876B1 (ko) 2004-11-17 2006-11-02 엘지전자 주식회사 이동 방송 수신기의 비디오 디코딩 시스템

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706255D0 (en) * 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
DK1001930T3 (da) * 1997-07-31 2003-03-24 Abbott Lab N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser
HUP0100597A3 (en) * 1998-01-30 2001-12-28 Darwin Discovery Ltd Cambridge Hydroxamic and carboxylic acid derivatives
BR9907681A (pt) * 1998-02-06 2000-10-24 Darwin Discovery Ltd Derivados de ácidos hidroxâmico e carboxìlico
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds

Also Published As

Publication number Publication date
CA2410294A1 (en) 2001-11-29
PL360116A1 (en) 2004-09-06
AR032341A1 (es) 2003-11-05
BR0111074A (pt) 2003-06-24
KR20030005392A (ko) 2003-01-17
CN1440400A (zh) 2003-09-03
ES2231513T3 (es) 2005-05-16
EP1289980A1 (en) 2003-03-12
EP1289980B1 (en) 2004-11-17
WO2001090100A1 (en) 2001-11-29
ATE282603T1 (de) 2004-12-15
NZ522594A (en) 2004-05-28
HUP0302121A2 (hu) 2003-10-28
DE60107240T2 (de) 2005-04-14
US20040024066A1 (en) 2004-02-05
IL152990A0 (en) 2003-06-24
DE60107240D1 (de) 2004-12-23
NO20025549D0 (no) 2002-11-19
CZ20023853A3 (cs) 2003-05-14
NO20025549L (no) 2003-01-24
AU2001267468A1 (en) 2001-12-03
US20050288376A1 (en) 2005-12-29
JP2004501108A (ja) 2004-01-15

Similar Documents

Publication Publication Date Title
BE2017C018I2 (es)
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
AU8473301A (en) Non-imidazole aryloxyalkylamines
DE60330150D1 (en) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
MY135841A (en) Novel benzodioxoles
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
PL341364A1 (en) 4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents
DE60112974D1 (en) Carbolinderivate
AU2002316459A1 (en) Methods of treating cytokine mediated diseases
DE60119790D1 (de) Indazolyl-substituierte pyrrolidin-verbindungen als kinase inhibitoren
GB0209891D0 (en) Novel compounds
GB0127903D0 (en) Improvements relating to organic compounds
DE60216233D1 (en) Carbolinderivate
MXPA03002911A (es) Compuestos quimicos.
NZ510369A (en) Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
MXPA02012076A (es) Compuestos quimicos.
MXPA02012659A (es) Derivados de pirazindiona condensados.
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
IL158324A0 (en) Arylsulphonamides as anttiviral agents
MXPA04006041A (es) Antivirales de piridoquinoxalina.
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
MXPA02011553A (es) N-hidroxiformamidas sustituidas por biciclico heterobiciclilmetansulfonilamino.
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren